Caris Life Sciences, Inc. Common Stock vs. Freenome, Inc. Common stock
CAI
Caris Life Sciences, Inc. Common Stock
$26.27 +6.88%
VS FRNMFreenome, Inc. Common stock
$13.81 +2.22%
Caris Life Sciences, Inc. Common Stock (CAI) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CAI | FRNM | |
|---|---|---|
| Market Cap | $6.95 billion | $1.47 billion |
| Revenue (TTM) | $989.61 million | — |
| Net Income (TTM) | $105.14 million | — |
CAI leads on 1 of 1 size & scale factors.
Valuation
| CAI | FRNM | |
|---|---|---|
| P/E Ratio | 15.54 | — |
| Price / Book | 11.74 | — |
| Price / Sales | 7.02 | — |
CAI and FRNM split the valuation factors evenly.
Profitability
| CAI | FRNM | |
|---|---|---|
| Net Margin | 10.62% | — |
| Return on Equity | 17.77% | — |
CAI and FRNM split the profitability factors evenly.
Dividend
| CAI | FRNM | |
|---|---|---|
| Dividend Yield | 4.57% | — |
| Payout Ratio | 71.01 | — |
CAI and FRNM split the dividend factors evenly.
Risk & Sentiment
| CAI | FRNM | |
|---|---|---|
| Short Interest | 0.13% | 0.42% |
CAI leads on 1 of 1 risk & sentiment factors.
Dig deeper: CAI overview, CAI financials, FRNM overview, FRNM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.